Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Microbial Fermentation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1563397A details a novel Stenotrophomonas maltophilia fermentation route for high-purity valienamine and validamine, offering scalable pharmaceutical intermediate production.
Patent CN105950679A reveals advanced fermentation for D-pantolactone. Enhances enzyme stability and reduces costs for vitamin B5 supply chains globally.
Advanced fermentation and resin purification method for echinocandin FR179642. Ensures high purity and scalable supply for global antifungal drug production.
Patent CN102190691B reveals a fermentation-based purification method for EPIDNR. Achieve over 97 percent purity with scalable resin technology for cost-effective API intermediate manufacturing.
Patent CN108559766A reveals novel microbial route for steroid intermediates. Achieve higher purity and yield with scalable fermentation for reliable pharmaceutical supply chains.
Patent CN102876582B details a novel Metarhizium anisopliae strain for efficient 11α-hydroxylation. This biocatalytic route offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN101760495A details a non-toxic bio-route for steroid 1,2-dehydrogenation using Arthrobacter simplex, ensuring high purity and scalable manufacturing for global supply chains.
Novel fermentation route for synthetic oak moss intermediate reduces complexity and ensures high purity supply for fragrance manufacturing.
Patent CN111116370A reveals a fermentation route for synthetic oak moss. This method ensures high purity and supply stability for fragrance manufacturing.
Patent CN112899191B reveals a green route from phytosterol to bile acids, offering supply chain stability and cost efficiency for pharmaceutical manufacturers.
Patent CN112342261B reveals a green route for prednisone acetate using RSA. Discover cost-effective biocatalytic hydroxylation and oxidation for high-purity steroid production.
Patent CN109680032B reveals a high-yield microbial route for steroid hydroxylation. Discover cost-effective manufacturing and reliable supply chain solutions for pharmaceutical intermediates.
Discover the advanced biocatalytic route for Pregna-5,7-diene-3β,21-diol described in CN110846370A. Achieve high purity and cost reduction in steroid manufacturing with our scalable solutions.
Patent CN110592169B reveals a dual-strain microbial method for high-purity ADD production, offering significant cost reduction in pharmaceutical manufacturing and robust supply chain reliability.
Patent CN110628860A reveals advanced biotransformation for steroid intermediates. Enhances purity and supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN117431292B reveals a high-yield one-step fermentation for 8DM. Discover cost reduction in steroid manufacturing and reliable supply chain solutions.
Patent CN110656146A reveals an oil-free method for DHEA production using protected phytosterol. This breakthrough offers high purity, reduced waste, and scalable manufacturing for pharmaceutical intermediates.
Patent CN1840684A details a high-yield Streptomyces fermentation route for nosiheptide. Discover cost-effective manufacturing and supply chain advantages for feed additives.
Patent CN102363796B details a microbial fermentation method for glycyrrhetinic acid using Aspergillus flavus, offering >98% purity and sustainable supply chain advantages.
Discover the patented CN1978457B method for 6α-methylprednisolone using cortisone acetate. High-yield biotransformation ensures supply chain reliability and cost efficiency.